25186-34-9 Usage
Uses
Used in Organic Synthesis:
3-Aminoacrolein is used as a reagent in organic synthesis for its ability to react with nucleophiles, facilitating the creation of various chemical compounds and structures.
Used in Pharmaceutical Research:
3-Aminoacrolein is utilized in the study of advanced glycation end products (AGEs), which are implicated in the pathogenesis of several diseases such as diabetes and Alzheimer's. Its role in understanding and potentially treating conditions associated with AGEs makes it a significant compound in pharmaceutical research.
Used in Environmental and Public Health Research:
In the context of tobacco-related diseases, 3-Aminoacrolein is a component of the combustion products of tobacco. It is used in research to investigate its contribution to the development of such diseases, aiding in the broader understanding of the harmful effects of tobacco smoke and potentially informing smoking cessation strategies and public health policies.
Check Digit Verification of cas no
The CAS Registry Mumber 25186-34-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,1,8 and 6 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 25186-34:
(7*2)+(6*5)+(5*1)+(4*8)+(3*6)+(2*3)+(1*4)=109
109 % 10 = 9
So 25186-34-9 is a valid CAS Registry Number.
25186-34-9Relevant academic research and scientific papers
Matveeva, E. D.,Tungusova, E. E.,Bundel',Yu. G.,Sagitullin, R. S.
, p. 1334 - 1336 (1986)
It is shown that the reaction of 3-aminoacrolein with cyclic ketones of medium size can be used to synthesize inaccessible 2,3-polymethylenepyridines with polymethylene chains of 5, 6, 10, and 12 carbon atoms.
SUBSTITUTE 1, 6-NAPHTHYRIDINES FOR USE AS SCD INHIBITORS
-
Page/Page column 40, (2009/06/27)
The present invention relates to substituted tetrahydronaphthyridine (THN) compounds of the formula (I) and salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for inhibiting SCD activity.
2-Amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
-
Page/Page column 29, (2010/11/08)
Novel compounds are provided which are glycogen phosphorylase inhibitors which are useful in treating, preventing or slowing the progression of diseases requiring glycogen phosphorylase inhibitor therapy such as diabetes and related conditions (such as hy
